Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Mode of action studies of the novel bisquaternary bisnaphthalimide MT02 against Staphylococcus aureus


ABSTRACT: Screening of various bisquaternary bisnaphthalimides against a variety of human pathogens revealed one compound, designated MT02, with strong inhibitory effects against gram-positive bacteria. The minimal inhibitory concentrations ranged from 0.31 µg/ml against community-acquired methicillin resistant Staphylococcus aureus (MRSA) strain USA300 to 20 µg/ml against Streptococcus pneumonia. DNA-microarray studies generated a transcriptional signature characterized by a strong increase of genes involved in DNA-metabolism, DNA-replication, SOS-response and transport of positively charged compounds. Radioactive whole cell labeling experiments indicated a strong impact of MT02 on bacterial DNA-replication. Furthermore, surface plasmon resonance and gel retardation experiments demonstrated direct binding of MT02 to DNA in a concentration dependent, reversible and sequence-unspecific manner. The data presented suggest that the bisquaternary bisnaphthalimide MT02 exerts anti-gram-positive activity by binding to DNA and thereby prohibiting appropriate DNA-replication. WT strain exposed to MT02 for 60 minutes in rich medium

ORGANISM(S): Staphylococcus aureus

SUBMITTER: FRANCOIS Patrice 

PROVIDER: E-GEOD-23077 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Mode-of-action studies of the novel bisquaternary bisnaphthalimide MT02 against Staphylococcus aureus.

Menzel Thomas M TM   Tischer Maximilian M   François Patrice P   Nickel Joachim J   Schrenzel Jacques J   Bruhn Heike H   Albrecht Annette A   Lehmann Leane L   Holzgrabe Ulrike U   Ohlsen Knut K  

Antimicrobial agents and chemotherapy 20101011 1


Screening of various bisquaternary bisnaphthalimides against a variety of human pathogens revealed one compound, designated MT02, with strong inhibitory effects against Gram-positive bacteria. The MICs ranged from 0.31 μg/ml against community-acquired methicillin-resistant Staphylococcus aureus (MRSA) lineage USA300 to 20 μg/ml against Streptococcus pneumoniae. Radioactive whole-cell labeling experiments indicated a strong impact of MT02 on bacterial DNA replication. DNA microarray studies gener  ...[more]

Similar Datasets

2011-01-04 | GSE23077 | GEO
2015-04-30 | E-GEOD-33832 | biostudies-arrayexpress
2011-12-02 | E-GEOD-28632 | biostudies-arrayexpress
2011-11-23 | E-GEOD-30115 | biostudies-arrayexpress
2014-11-21 | E-GEOD-47101 | biostudies-arrayexpress
2012-01-12 | E-GEOD-29309 | biostudies-arrayexpress
2010-09-02 | E-GEOD-23939 | biostudies-arrayexpress
2021-06-01 | GSE172417 | GEO
2022-07-15 | E-MTAB-11459 | biostudies-arrayexpress
2018-07-03 | GSE116503 | GEO